Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium

J Clin Psychiatry. 2010 May;71(5):649-50. doi: 10.4088/JCP.10ac06132gre.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anticonvulsants / therapeutic use*
  • Antimanic Agents / therapeutic use*
  • Depressive Disorder / drug therapy
  • Drug Monitoring*
  • Epilepsy / drug therapy
  • Female
  • Humans
  • Lamotrigine
  • Lithium Compounds / therapeutic use*
  • Postpartum Period / drug effects*
  • Practice Guidelines as Topic
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • Serotonin Uptake Inhibitors / therapeutic use*
  • Triazines / therapeutic use*

Substances

  • Anticonvulsants
  • Antimanic Agents
  • Lithium Compounds
  • Serotonin Uptake Inhibitors
  • Triazines
  • Lamotrigine